Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | $17.79M | $0.28 | $10.00 | 3,523.19% | Buy | 2 | 481.39% | N/A | N/A | N/A | ||||
| ASLN | ASLAN PHARMACEUTICALS LTD | $7.47M | $0.40 | $9.50 | 2,275.00% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| PPBT | PURPLE BIOTECH LTD | $10.12M | $0.51 | $10.50 | 1,958.82% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| IQ | IQIYI INC | $4.65B | $4.84 | $94.00 | 1,842.15% | Strong Buy | 3 | 5.23% | 11.41% | N/A | N/A | ||||
| INTZ | INTRUSION INC | $5.02M | $2.58 | $50.00 | 1,837.98% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| CLNN | CLENE INC | $49.32M | $0.38 | $6.00 | 1,462.50% | Strong Buy | 2 | 107.04% | N/A | N/A | N/A | ||||
| BPTH | BIO-PATH HOLDINGS INC | $4.27M | $2.58 | $40.00 | 1,450.39% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| GOEV | CANOO INC | $179.67M | $2.79 | $40.35 | 1,346.24% | Strong Buy | 5 | 924.84% | N/A | N/A | N/A | ||||
| CLDI | CALIDI BIOTHERAPEUTICS INC | $11.51M | $0.23 | $3.25 | 1,338.05% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| BIOL | BIOLASE INC | $5.14M | $0.15 | $2.20 | 1,328.57% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| LIFE | ATYR PHARMA INC | $125.60M | $1.82 | $25.50 | 1,301.10% | Buy | 2 | 431.52% | N/A | N/A | N/A | ||||
| BNED | BARNES & NOBLE EDUCATION INC | $10.10M | $0.19 | $2.63 | 1,281.58% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| CKPT | CHECKPOINT THERAPEUTICS INC | $57.49M | $1.56 | $19.00 | 1,117.95% | Strong Buy | 2 | 1,649.52% | N/A | N/A | N/A | ||||
| LYRA | LYRA THERAPEUTICS INC | $22.68M | $0.37 | $4.50 | 1,109.68% | Buy | 3 | 69.97% | N/A | N/A | N/A | ||||
| APLM | APOLLOMICS INC | $31.77M | $0.36 | $4.25 | 1,097.18% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| GOSS | GOSSAMER BIO INC | $165.82M | $0.73 | $8.60 | 1,073.26% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| APTO | APTOSE BIOSCIENCES INC | $20.06M | $1.23 | $14.00 | 1,038.21% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| OCUP | OCUPHIRE PHARMA INC | $44.07M | $1.70 | $19.33 | 1,037.24% | Strong Buy | 3 | 47.02% | N/A | N/A | N/A | ||||
| VIRX | VIRACTA THERAPEUTICS INC | $31.58M | $0.80 | $8.50 | 957.21% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| MVST | MICROVAST HOLDINGS INC | $138.93M | $0.44 | $4.50 | 927.40% | Buy | 4 | 31.17% | N/A | N/A | N/A | ||||
| YTEN | YIELD10 BIOSCIENCE INC | $3.38M | $5.26 | $54.00 | 926.62% | Buy | 2 | 658.60% | N/A | N/A | N/A | ||||
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | $5.63M | $1.81 | $18.50 | 922.10% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $50.95M | $1.83 | $18.50 | 913.70% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| SYBX | SYNLOGIC INC | $20.49M | $1.75 | $15.50 | 785.71% | Buy | 2 | 89.51% | N/A | N/A | N/A | ||||
| MIST | MILESTONE PHARMACEUTICALS INC | $91.61M | $1.72 | $15.00 | 772.09% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| GNLX | GENELUX CORP | $96.65M | $3.58 | $31.00 | 765.92% | Buy | 2 | 2,779.57% | N/A | N/A | N/A | ||||
| LUMO | LUMOS PHARMA INC | $20.67M | $2.55 | $22.00 | 762.75% | Buy | 2 | 180.56% | N/A | N/A | N/A | ||||
| ACET | ADICET BIO INC | $109.29M | $1.33 | $11.33 | 752.11% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| FEMY | FEMASYS INC | $30.66M | $1.38 | $11.67 | 745.43% | Strong Buy | 3 | 208.06% | N/A | N/A | N/A | ||||
| IMRX | IMMUNEERING CORP | $47.45M | $1.60 | $13.40 | 737.50% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| PRST | PRESTO AUTOMATION INC | $12.77M | $0.16 | $1.31 | 729.11% | Buy | 2 | 27.03% | N/A | N/A | N/A | ||||
| CARA | CARA THERAPEUTICS INC | $39.59M | $0.72 | $5.83 | 705.66% | Strong Buy | 3 | -19.00% | N/A | N/A | N/A | ||||
| INAB | IN8BIO INC | $45.89M | $1.04 | $8.33 | 701.25% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| CVKD | CADRENAL THERAPEUTICS INC | $7.06M | $0.44 | $3.50 | 693.65% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| TARA | PROTARA THERAPEUTICS INC | $68.77M | $3.34 | $26.50 | 693.41% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| MRNS | MARINUS PHARMACEUTICALS INC | $73.61M | $1.34 | $10.50 | 683.58% | Buy | 6 | 61.50% | N/A | N/A | N/A | ||||
| GEVO | GEVO INC | $172.21M | $0.73 | $5.68 | 679.56% | Buy | 3 | 73.38% | N/A | N/A | N/A | ||||
| AMPX | AMPRIUS TECHNOLOGIES INC | $122.81M | $1.30 | $10.00 | 669.23% | Strong Buy | 5 | 169.76% | N/A | N/A | N/A | ||||
| DDC | DDC ENTERPRISE LTD | N/A | $0.73 | $5.50 | 653.42% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| SGMT | SAGIMET BIOSCIENCES INC | $139.78M | $4.38 | $32.75 | 647.72% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| VOR | VOR BIOPHARMA INC | $114.68M | $1.68 | $12.50 | 644.05% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| TPST | TEMPEST THERAPEUTICS INC | $75.54M | $3.40 | $25.00 | 635.29% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| PGEN | PRECIGEN INC | $345.81M | $1.37 | $10.00 | 629.93% | Buy | 2 | 212.49% | N/A | N/A | N/A | ||||
| NTBL | NOTABLE LABS LTD | $9.92M | $1.10 | $8.00 | 627.27% | Strong Buy | 2 | 24.62% | N/A | N/A | N/A | ||||
| OTLK | OUTLOOK THERAPEUTICS INC | $96.30M | $7.40 | $53.57 | 623.88% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| MBRX | MOLECULIN BIOTECH INC | $11.21M | $4.85 | $35.00 | 621.65% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| IKNA | IKENA ONCOLOGY INC | $64.18M | $1.33 | $9.50 | 614.29% | Buy | 2 | 115.73% | N/A | N/A | N/A | ||||
| FBIO | FORTRESS BIOTECH INC | $33.85M | $1.76 | $12.50 | 610.23% | Strong Buy | 2 | 25.32% | N/A | N/A | N/A | ||||
| EOSE | EOS ENERGY ENTERPRISES INC | $170.66M | $0.82 | $5.67 | 591.10% | Strong Buy | 3 | 400.51% | N/A | N/A | N/A | ||||
| NOTV | INOTIV INC | $54.68M | $2.12 | $14.38 | 578.07% | Buy | 2 | -1.09% | N/A | N/A | N/A | ||||
| CMPS | COMPASS PATHWAYS PLC | $558.67M | $8.17 | $55.33 | 577.27% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| SPRB | SPRUCE BIOSCIENCES INC | $33.95M | $0.83 | $5.40 | 554.55% | Buy | 5 | 84.41% | N/A | N/A | N/A | ||||
| AGEN | AGENUS INC | $224.69M | $10.70 | $70.00 | 554.21% | Strong Buy | 2 | 16.71% | N/A | N/A | N/A | ||||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $12.51M | $0.88 | $5.67 | 543.98% | Strong Buy | 3 | N/A | N/A | -10,239.47% | -7,579.68% | ||||
| AQMS | AQUA METALS INC | $52.73M | $0.47 | $3.00 | 536.94% | Buy | 2 | 1,334.38% | N/A | N/A | N/A | ||||
| CLRB | CELLECTAR BIOSCIENCES INC | $114.00M | $3.18 | $20.00 | 528.93% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| LCTX | LINEAGE CELL THERAPEUTICS INC | $196.35M | $1.04 | $6.50 | 525.00% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| SGMO | SANGAMO THERAPEUTICS INC | $117.87M | $0.57 | $3.50 | 516.20% | Buy | 2 | 65.12% | N/A | N/A | N/A | ||||
| RIGL | RIGEL PHARMACEUTICALS INC | $166.29M | $0.95 | $5.81 | 513.19% | Buy | 4 | 22.42% | N/A | N/A | N/A | ||||
| IVA | INVENTIVA SA | $190.22M | $3.65 | $22.33 | 511.86% | Strong Buy | 3 | -1.30% | N/A | N/A | N/A | ||||
| HOOK | HOOKIPA PHARMA INC | $81.63M | $0.83 | $5.00 | 506.06% | Buy | 2 | -52.99% | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.